Part of the Cannabis Intelligence Briefing series.
As pharmaceutical companies race to bring cannabis-based medicines to market, it’s increasingly important to keep track of how this sector of the cannabis business is evolving. This report provides an overview of the pharmaceutical industry’s activity in the cannabis space to date as well as a deep look at what’s in the pipeline and how we can expect pharma to interact with existing medical cannabis markets.
Get the latest industry data to drive your decisions
Please be advised you are leaving the Arcview Group domain.